In March, e-MSion entered an exciting new stage of development by officially joining forces with Agilent Technologies.
From the start, we’ve aimed to bring the power of electron-based fragmentation for biomolecule characterization to a wider audience. By taking this next step with Agilent, we’re excited by the opportunity to provide users with a fully integrated ExD-MS experience.
We are deeply grateful to our customers, collaborators, partners, team, advisors, and friends—all of whom were essential to helping us reach this milestone. We could not have done it without your support.
Thanks,
The e-MSion Team
